Mark J. Gilbert - 10 Jun 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship
Director
Issuer ticker
INDP
Reported as of
10 Jun 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Jun 2025, 16:05:11 UTC
Prior SEC filing
07 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark J. Gilbert

Key filing fact

Mark J. Gilbert filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 11 Jun 2025.

Key facts

  • This page summarizes Mark J. Gilbert's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 11 Jun 2025, 16:05.

Change

  • Previous filing in this sequence was filed on 07 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001897698 Primary reporting owner

Gilbert Mark John

Relationship
Director
Address
C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
Signature
/s/ Mark J. Gilbert
Signature date
11 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INDP transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+12,500
Change %
Price
$0.000000
Shares after
12,500
Date
10 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$0.3300
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests and becomes exercisable on June 10, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .